previous compound ID: 901 next compound
InChIKey: HXYVTAGFYLMHSO-UHFFFAOYSA-N
SMILES: CCCCCCCCCCCCCCCC(=O)NCCO

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"J Liao" "E Matthes" "J Goepp" "DY Thomas" "R Robert" "D Rotin" "JW Hanrahan" "B Kus" "SD Macknight" "GW Carlile"

chemical graph of compound 901





CID is 4671
synonyms found at PubChem are:
Palmitoylethanolamide, Palmidrol, 544-31-0, N-(2-Hydroxyethyl)hexadecanamide, Palmitamide MEA, Hydroxyethylpalmitamide, N-palmitoylethanolamine, N-(2-Hydroxyethyl)palmitamide, Palmitoyl ethanolamide, Impulsin, Palmitic acid monoethanolamide, Loramine P 256, Palmitoyl-EA, Palmidrolum, palmitylethanolamide, HEXADECANAMIDE, N-(2-HYDROXYETHYL)-, Palmidrol [INN], Anandamide (16:0), Palmidrolum [INN-Latin], Palmitinsaeure-beta-hydroxyethylamid, UNII-6R8T1UDM3V, Monoethanolamine palmitic acid amide, NSC 23320, hexadecanoyl ethanolamide, N-palmitoyl ethanolamine, EINECS 208-867-9, N-hexadecanoyl-ethanolamine, 6R8T1UDM3V, C18H37NO2, CHEBI:71464, HXYVTAGFYLMHSO-UHFFFAOYSA-N, Palmidrol (INN), Hexadecanamide,N-(2-hydroxyethyl)-, AM 3112, NCGC00015793-03, DSSTox_CID_22254, DSSTox_RID_79975, DSSTox_GSID_42254, MimyX, CAS-544-31-0, SR-01000076055, N-(2-hydroxyethyl)palmitate, 2-Palmitoylaminoethanol, Palmdrol prodes (TN), Tocris-0879, palmitic monoethanolamide, AC1L1IOV, AC1Q5PML, N-hexadecanoylethanolamine, Lopac-P-0359, Guanfacine extended release, D07ILQ, D08HMQ, D0M1FB, Palmityoletanolamide (PEA), CBiol_002043, Lopac0_000905, BSPBio_001454, KBioGR_000174, KBioSS_000174, MLS002153421, SCHEMBL120518, BML2-B10, CHEMBL417675, GTPL3622, DTXSID4042254, Palmidrol|N-palmitoylethanolamine, SCHEMBL19511663, BDBM29083, CTK8E7798, KBio2_000174, KBio2_002742, KBio2_005310, KBio3_000347, KBio3_000348, MolPort-003-708-445, Bio1_000329, Bio1_000818, Bio1_001307, Bio2_000174, Bio2_000654, HMS1361I16, HMS1791I16, HMS1989I16, HMS2234L19, HMS3264C10, HMS3266N08, HMS3374K03, HMS3402I16, HMS3649L03, N-(2-hydroxyethyl) hexadecanamide, Pharmakon1600-01506156, BCP29005, CS-D1253, NSC23320, ZINC8035017, Tox21_110222, BN0405, LMFA08040013, MFCD00020562, NSC-23320, NSC760371, s4708, STL454872, AKOS002676363, Tox21_110222_1, CCG-204987, LP00905, NSC-760371, TRA0000334, IDI1_033924, NCGC00015793-01, NCGC00015793-02, NCGC00015793-04, NCGC00015793-05, NCGC00015793-06, NCGC00015793-07, NCGC00015793-08, NCGC00015793-09, NCGC00015793-10, NCGC00024840-01, NCGC00024840-02, NCGC00024840-05, NCGC00024840-06, NCGC00024840-07, NCGC00024840-08, NCGC00024840-09, AS-14094, HY-20685, SMR000058371, LS-175551, TX-017897, B6485, EU-0100905, V1640, C16512, D08328, J90064, P 0359, AB00918319_06, SR-01000076055-1, SR-01000076055-3, SR-01000076055-7, BRD-K68095457-001-04-4, Z2687203832, UNII-3VVG2UI23S component HXYVTAGFYLMHSO-UHFFFAOYSA-N, Amides, C16-18 and C18-branched, unsatd., N-(hydroxyethyl), UNII-C80684146D component HXYVTAGFYLMHSO-UHFFFAOYSA-N, 71060-58-7